34 related articles for article (PubMed ID: 38532575)
1. Ukraine Data on Prognostic Factors and Treatment Outcomes in Patients with Peripheral T-Cell Lymphomas.
Skrypets T; Novosad O; Pastushenko Y; Gorbach O; Kriachok I
Klin Onkol; 2019; 32(6):436-444. PubMed ID: 31842562
[TBL] [Abstract][Full Text] [Related]
2. Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
Tomita N; Motomura S; Hyo R; Takasaki H; Takemura S; Taguchi J; Fujisawa S; Ogawa K; Ishigatsubo Y; Takeuchi K
Cancer; 2007 Mar; 109(6):1146-51. PubMed ID: 17311304
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project.
Chiattone C; Civallero M; Fischer T; Miranda E; Manni M; Zing NPC; Pileri SA; Montoto S; Horwitz SM; Cabrera ME; De Souza CA; Nagler A; Luminari S; Ferreri AJM; Carson KR; Re A; Rigacci L; Nassi L; Stepanishyna Y; Federico M; Inghirami G
Hematol Oncol; 2022 Dec; 40(5):953-961. PubMed ID: 36083035
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
Advani RH; Skrypets T; Civallero M; Spinner MA; Manni M; Kim WS; Shustov AR; Horwitz SM; Hitz F; Cabrera ME; Dlouhy I; Vassallo J; Pileri SA; Inghirami G; Montoto S; Vitolo U; Radford J; Vose JM; Federico M
Blood; 2021 Jul; 138(3):213-220. PubMed ID: 34292324
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project.
Civallero M; Schroers-Martin JG; Horwitz S; Manni M; Stepanishyna Y; Cabrera ME; Vose J; Spina M; Hitz F; Nagler A; Montoto S; Chiattone C; Skrypets T; Perez Saenz MA; Priolo G; Luminari S; Lymboussaki A; Pavlovsky A; Marino D; Liberati M; Trotman J; Mannina D; Federico M; Advani R
Br J Haematol; 2024 Mar; ():. PubMed ID: 38532575
[TBL] [Abstract][Full Text] [Related]
6. The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project.
Bellei M; Nabhan C; Pesce EA; Conte L; Vose JM; Foss F; Federico M
Curr Hematol Malig Rep; 2015 Dec; 10(4):448-55. PubMed ID: 26449717
[TBL] [Abstract][Full Text] [Related]
7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
8. The role of high-dose therapy in peripheral T-cell lymphomas.
Reimer P; Rüdiger T; Wilhelm M
Clin Lymphoma Myeloma; 2006 Mar; 6(5):373-9. PubMed ID: 16640812
[TBL] [Abstract][Full Text] [Related]
9. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
10. Updates in the Treatment of Peripheral T-Cell Lymphomas.
Saleh K; Michot JM; Ribrag V
J Exp Pharmacol; 2021; 13():577-591. PubMed ID: 34188559
[TBL] [Abstract][Full Text] [Related]
11. What's new in peripheral T-cell lymphomas.
Luminari S; Skrypets T
Hematol Oncol; 2021 Jun; 39 Suppl 1(Suppl 1):52-60. PubMed ID: 34105820
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
